Skip to content

ASSERTIO THERAPEUTICS, INC.

CIK 0001005201

← back to feed
Revenue (TTM)
$191.2M
+7.4% YoY Q2 Dec 2020
Net Income (TTM)
$16.66M
−5,882.8% YoY Q2 Dec 2020
EPS Diluted (TTM)
$0.20
−5,400.0% YoY Q2 Dec 2020
Gross Margin
15.0%
Q2 Dec 2020
Operating Margin
-10.5%
Q2 Dec 2020
Net Margin
8.7%
Q2 Dec 2020
Free Cash Flow (TTM)
−$9.33M
Q2 Dec 2020
Cash
$22.53M
Q2 Dec 2020
Total Debt
—
Q2 Dec 2020
Shares Outstanding
81.38M sh
Q2 Dec 2020

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings